Fuji Pharma Co., Ltd. (4554.T)
JPY 1536.0
(0.26%)
JPY 1536.0
(0.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 85.33 Billion JPY | 12.97% |
| 2022 | 75.53 Billion JPY | 17.59% |
| 2021 | 64.23 Billion JPY | 3.67% |
| 2020 | 61.96 Billion JPY | 2.02% |
| 2019 | 60.73 Billion JPY | 14.35% |
| 2018 | 53.11 Billion JPY | 7.2% |
| 2017 | 49.55 Billion JPY | 2.92% |
| 2016 | 48.14 Billion JPY | 5.19% |
| 2015 | 45.77 Billion JPY | -6.64% |
| 2014 | 49.02 Billion JPY | 25.27% |
| 2013 | 39.13 Billion JPY | 24.36% |
| 2012 | 31.47 Billion JPY | 5.76% |
| 2011 | 29.75 Billion JPY | 20.36% |
| 2010 | 24.72 Billion JPY | 8.14% |
| 2009 | 22.86 Billion JPY | 12.32% |
| 2008 | 20.35 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 85 Billion JPY | 0.5% |
| 2024 Q1 | 84.58 Billion JPY | -0.88% |
| 2024 Q3 | 88.47 Billion JPY | 4.08% |
| 2023 Q2 | 84.8 Billion JPY | 5.09% |
| 2023 Q4 | 85.33 Billion JPY | 1.11% |
| 2023 FY | 85.33 Billion JPY | 12.97% |
| 2023 Q1 | 80.69 Billion JPY | 6.83% |
| 2023 Q3 | 84.39 Billion JPY | -0.48% |
| 2022 Q3 | 74.1 Billion JPY | -0.27% |
| 2022 Q1 | 64.04 Billion JPY | -0.3% |
| 2022 Q2 | 74.29 Billion JPY | 16.01% |
| 2022 FY | 75.53 Billion JPY | 17.59% |
| 2022 Q4 | 75.53 Billion JPY | 1.94% |
| 2021 Q3 | 61.95 Billion JPY | -0.97% |
| 2021 Q1 | 62.91 Billion JPY | 1.53% |
| 2021 FY | 64.23 Billion JPY | 3.67% |
| 2021 Q4 | 64.23 Billion JPY | 3.68% |
| 2021 Q2 | 62.56 Billion JPY | -0.56% |
| 2020 FY | 61.96 Billion JPY | 2.02% |
| 2020 Q2 | 58.16 Billion JPY | -1.26% |
| 2020 Q3 | 62.6 Billion JPY | 7.63% |
| 2020 Q1 | 58.9 Billion JPY | -3.01% |
| 2020 Q4 | 61.96 Billion JPY | -1.02% |
| 2019 Q2 | 59.01 Billion JPY | 12.58% |
| 2019 Q3 | 60.84 Billion JPY | 3.1% |
| 2019 Q4 | 60.73 Billion JPY | -0.18% |
| 2019 FY | 60.73 Billion JPY | 14.35% |
| 2019 Q1 | 52.41 Billion JPY | -1.32% |
| 2018 FY | 53.11 Billion JPY | 7.2% |
| 2018 Q4 | 53.11 Billion JPY | 4.29% |
| 2018 Q3 | 50.93 Billion JPY | 2.18% |
| 2018 Q2 | 49.84 Billion JPY | -2.22% |
| 2018 Q1 | 50.98 Billion JPY | 2.89% |
| 2017 Q2 | 47.52 Billion JPY | -2.43% |
| 2017 Q1 | 48.7 Billion JPY | 1.16% |
| 2017 FY | 49.55 Billion JPY | 2.92% |
| 2017 Q4 | 49.55 Billion JPY | 1.44% |
| 2017 Q3 | 48.85 Billion JPY | 2.79% |
| 2016 Q1 | 47.61 Billion JPY | 4.02% |
| 2016 FY | 48.14 Billion JPY | 5.19% |
| 2016 Q3 | 47.07 Billion JPY | -1.2% |
| 2016 Q4 | 48.14 Billion JPY | 2.28% |
| 2016 Q2 | 47.64 Billion JPY | 0.07% |
| 2015 Q3 | 46.18 Billion JPY | -2.13% |
| 2015 Q2 | 47.18 Billion JPY | -1.0% |
| 2015 Q1 | 47.66 Billion JPY | -2.78% |
| 2015 FY | 45.77 Billion JPY | -6.64% |
| 2015 Q4 | 45.77 Billion JPY | -0.89% |
| 2014 Q2 | 41.41 Billion JPY | 2.01% |
| 2014 Q1 | 40.59 Billion JPY | 3.73% |
| 2014 FY | 49.02 Billion JPY | 25.27% |
| 2014 Q3 | 44.63 Billion JPY | 7.79% |
| 2014 Q4 | 49.02 Billion JPY | 9.83% |
| 2013 FY | 39.13 Billion JPY | 24.36% |
| 2013 Q1 | 37.36 Billion JPY | 18.72% |
| 2013 Q4 | 39.13 Billion JPY | 3.83% |
| 2013 Q2 | 38.83 Billion JPY | 3.93% |
| 2013 Q3 | 37.69 Billion JPY | -2.94% |
| 2012 FY | 31.47 Billion JPY | 5.76% |
| 2012 Q4 | 31.47 Billion JPY | 3.0% |
| 2012 Q3 | 30.55 Billion JPY | 3.46% |
| 2012 Q2 | 29.53 Billion JPY | 1.05% |
| 2012 Q1 | 29.22 Billion JPY | -1.78% |
| 2011 FY | 29.75 Billion JPY | 20.36% |
| 2011 Q3 | 26.86 Billion JPY | 1.63% |
| 2011 Q1 | 25.82 Billion JPY | 4.47% |
| 2011 Q4 | 29.75 Billion JPY | 10.78% |
| 2011 Q2 | 26.43 Billion JPY | 2.33% |
| 2010 Q3 | 23.36 Billion JPY | -1.4% |
| 2010 Q1 | 22.43 Billion JPY | -1.88% |
| 2010 Q2 | 23.69 Billion JPY | 5.63% |
| 2010 FY | 24.72 Billion JPY | 8.14% |
| 2010 Q4 | 24.72 Billion JPY | 5.82% |
| 2009 Q2 | 20.6 Billion JPY | 2.7% |
| 2009 Q1 | 20.06 Billion JPY | 0.0% |
| 2009 Q4 | 22.86 Billion JPY | 0.0% |
| 2009 FY | 22.86 Billion JPY | 12.32% |
| 2008 FY | 20.35 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -133.32% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 99.435% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 90.597% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 93.978% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -453.347% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 67.604% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 50.279% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 93.878% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -396.607% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 74.046% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | 46.264% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -11.603% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -72.221% |
| Tsumura & Co. | 428.25 Billion JPY | 80.074% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 67.297% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | 36.048% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 80.185% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | 43.314% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | 51.974% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -467.141% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -9.811% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -455.835% |
| MedRx Co., Ltd | 2.05 Billion JPY | -4058.48% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -350.341% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -3246.353% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -4112.002% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | 8.552% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 77.663% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -1924.576% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 88.967% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -166.629% |